Related Experiment Video
Updated: Aug 25, 2026
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Evidence-based guidelines for managing mucositis
Deborah B McGuire1, Edward B Rubenstein, Douglas E Peterson
1School of Nursing, University of Maryland, Baltimore, MD 21201, USA.
Objectives:
To discuss implementation of evidence-based clinical practice guidelines for mucositis.
Data Source:
Published articles, book chapters, web sources, clinical experience, unpublished manuscripts.
Conclusion:
Nurses can implement evidence-based guidelines but must include an evaluation component to determine effect on clinical outcomes.
Implications For Nursing Practice:
Nurses have an integral role implementing and evaluating evidence-based practice guidelines for managing mucositis. When evidence is lacking and guidelines have gaps, nurses can play important roles in research to overcome these gaps.
Related Concept Videos
01:26Tonsillitis II: Management
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...